There being no definitive cure is what that cancer so scary. Also, the available treatments including chemotherapy and radiotherapy pose harm to normal cells and affects patient's immune system. Now, Intel has come up with a new project known as Collaborative Cancer Cloud that aims to promote precision medicine.

Eric Dishman, current health and life sciences writer of Intel, explained about the CCC that it will act as a service tool that will encourage personalized medicine through analytics. For precision medicine, there is a need of a person's genome to be studied so that disease's nature can be understood.

After fully understanding the disease, a tailored treatment is formed that results into better outcome in comparison to available treatments. Another advantage of this platform will be collaborative usage, which means that a number of doctors, researchers and members of medicine field are able to share the genetic data, but in a secured setting.

Being present in the cloud, the genetic data is available anytime and anywhere. As the data will gather, it will now be possible to have a targeted solution for a particular type of cancer and that too in 24 hours. Intel is hoping to actualize it by 2020.

Intel has partnered with Oregon Health and Science University. Intel said that by next year, at least two more institutions will participate, so that the number of patients in the database can be increased.